Bettina LICHDI-BALLESTEROS - Comment

Document ID: FDA-2000-P-0102-0057
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: October 24 2011, at 12:00 AM Eastern Daylight Time
Date Posted: November 4 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 11 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: October 25 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f5a9d2
View Document:  View as format xml

View Comment

-----Original Message----- From: eu-tbt@ec.europa.eu [mailto:eu-tbt@ec.europa.eu] Sent: Monday, October 24, 2011 3: AM To: ncsci Subject: WTO Notification G/TBT/N/USA/606/Add.1 : Extension Request. Dear Sir or Madam, This is to inform you that the European Union is currently reviewing the draft regulation notified under G/TBT/N/USA/606/Add.1. The final date for providing comments on the notification is October, 25 2011. The European Communities are requesting that the comment deadline date be extended to November, 25 2011. I look forward to your favorable response to this request. Please do not hesitate to communicate with me if you have any questions. Your acknowledgement of receiving this request would be greatly appreciated. Yours faithfully, Bettina LICHDI-BALLESTEROS EU-WTO-TBT Enquiry Point European Commission Entreprise and Industry Directorate-General, unit C/3 e-mail : eu-tbt@ec.europa.eu tel :50862 TBT-Europa website : http://ec.europa.eu/enterprise/tbt/

Related Comments

   
Total: 4
Pfizer Consumer Healthcare - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2000-P-0102-0056

Oct 25,2011 11:59 PM ET
Bettina LICHDI-BALLESTEROS - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2000-P-0102-0057

Oct 25,2011 11:59 PM ET
Pharmavite LLC - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2000-P-0102-0058

Oct 25,2011 11:59 PM ET
Banner Pharmacaps, Inc. - Comment
Public Submission    Posted: 03/28/2012     ID: FDA-2000-P-0102-0060

Oct 25,2011 11:59 PM ET